We are live on ! Find out more
AEON.WS

AEON Biopharma Inc
AEON.WS

Delisted

AEON.WS was delisted on the 26th of April, 2024.

Back to rankings

39 hedge funds and large institutions have $6.66M invested in AEON Biopharma Inc in 2021 Q2 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
39
Holders Change
+39
Holders Change %
–
% of All Funds
0.68%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
–
Reduced
–
Closed
–
Calls
$1.09M
Puts
–
Net Calls
+$1.09M
Net Calls Change
+$1.09M

Top Buyers

Rank Fund Capital Flow
1
DKCM
Davidson Kempner Capital Management
New York
+$278K
2
RCM
Radcliffe Capital Management
Pennsylvania
+$219K
3
LA
Linden Advisors
New York
+$152K
4
LP
LMR Partners
United Kingdom
+$152K
5
Citadel Advisors
Citadel Advisors
Florida
+$150K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RCM
1
Radcliffe Capital Management
Pennsylvania
$2.78M +$219K +288,829 New
DKCM
2
Davidson Kempner Capital Management
New York
$367K +$278K +366,671 New
AC
3
Athos Capital
Hong Kong
$287K +$22.6K +29,768 New
LA
4
Linden Advisors
New York
$204K +$152K +200,000 New
Citadel Advisors
5
Citadel Advisors
Florida
$200K +$150K +197,918 New
LP
6
LMR Partners
United Kingdom
$200K +$152K +200,000 New
CC
7
Covalis Capital
United Kingdom
$185K +$31.6K +41,665 New
UOC
8
UBS O'Connor
Illinois
$171K +$126K +166,660 New
FTCM
9
Fir Tree Capital Management
New York
$168K +$126K +166,664 New
PC
10
Periscope Capital
Ontario, Canada
$167K +$126K +166,300 New
Blackstone Inc
11
Blackstone Inc
New York
$167K +$126K +166,666 New
CH
12
CVI Holdings
Delaware
$167K +$126K +166,666 New
TCM
13
Tenor Capital Management
New York
$167K +$126K +166,666 New
PAMP
14
Polar Asset Management Partners
Ontario, Canada
$150K +$114K +149,900 New
PMAM
15
Picton Mahoney Asset Management
Ontario, Canada
$117K +$88.5K +116,666 New
Hudson Bay Capital Management
16
Hudson Bay Capital Management
Connecticut
$101K +$75.9K +100,000 New
Verition Fund Management
17
Verition Fund Management
Connecticut
$100K +$75.9K +100,000 New
Wells Fargo
18
Wells Fargo
California
$90K +$71.9K +94,674 New
CCA
19
Castle Creek Arbitrage
Colorado
$85K +$64.6K +85,056 New
SCC
20
Spring Creek Capital
Kansas
$83K +$63.3K +83,333 New
Goldman Sachs
21
Goldman Sachs
New York
$79K +$60.3K +79,384 New
Balyasny Asset Management
22
Balyasny Asset Management
Illinois
$67K +$50.6K +66,666 New
GPCM
23
Granite Point Capital Management
Massachusetts
$67K +$50.6K +66,666 New
WAM
24
Wolverine Asset Management
Illinois
$57K +$43.3K +57,076 New
FIG
25
Fortress Investment Group
New York
$51K +$37.9K +49,999 New
1
2

AEON.WS Hedge Fund Activity: Q2 2021 in Review

39 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma Inc (AEON.WS) for Q2 2021, worth a combined $6.66M.

Buyers outnumbered sellers: 39 funds opened new AEON.WS positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Davidson Kempner Capital Management, opening a new position worth an estimated $278K.

  • 39 institutional investors held AEON Biopharma Inc (AEON.WS) as of Q2 2021, up from 0 in Q1 2021.
  • Funds reported $6.66M of AEON Biopharma Inc stock for Q2 2021.
  • 39 funds opened new AEON Biopharma Inc positions in Q2 2021 and 0 closed out, a net change of +39 holders.
  • The largest AEON Biopharma Inc buyer in Q2 2021 was Davidson Kempner Capital Management, an estimated $278K added.

Based on aggregated 13F filings for Q2 2021.